<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02110719</url>
  </required_header>
  <id_info>
    <org_study_id>REAG00414HU</org_study_id>
    <nct_id>NCT02110719</nct_id>
  </id_info>
  <brief_title>Decreasing Narcotics in Advanced Pelvic Surgery</brief_title>
  <acronym>Pain</acronym>
  <official_title>Decreasing Narcotics in Advanced Pelvic Surgery: A Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hartford Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hartford Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In recent years, there has been an emphasis on the creation of &quot;enhanced-recovery&quot;,
      &quot;fast-track&quot; or &quot;multi-modal&quot; pathways to improve perioperative care (1-4). The goal of these
      programs is to reduce the length of hospital stay, decrease narcotic usage while improving
      pain control, accelerate post-operative recovery, and expedite return to baseline functional
      status. Pathways often are developed by a team of surgeons, nurses, pain specialists,
      anesthesiologists and other support staff. Postoperative components often involve multi-modal
      analgesia, early return to activity and early return to a regular diet. The goal of this
      study is to evaluate the efficacy of a multi-modal pain regimen in advanced pelvic surgery
      with a primary goal of decreasing narcotic usage.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Actual">June 2016</completion_date>
  <primary_completion_date type="Actual">July 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Narcotic use</measure>
    <time_frame>intraoperative, immediate postoperative and 1 week postoperative</time_frame>
    <description>Narcotic use will be evaluated at all stages of the preoperative care: operating room, hospital floor and at the 1 week postoperative time point</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain</measure>
    <time_frame>postoperative day #1 and postoperative week #1</time_frame>
    <description>pain will be evaluated at the above listed time points using the validated brief pain inventory</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nausea</measure>
    <time_frame>intraoperatively, postoperatively</time_frame>
    <description>Nausea will be evaluated based on the use of narcotics in the hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Constipation</measure>
    <time_frame>one week postoperatively</time_frame>
    <description>constipation at the time of the first bowel movement will be evaluated using the validated Bristol Stool Scale</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">138</enrollment>
  <condition>Narcotic Use</condition>
  <condition>Pain</condition>
  <condition>Constipation</condition>
  <condition>Nausea</condition>
  <arm_group>
    <arm_group_label>Standard</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will be given the following:
no preoperative medications
intraoperative medications per anesthesia
postoperatively, patients will receive ibuprofen, tylenol and narcotics as needed</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Multimodal</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in the multimodal arm will receive the following:
preoperative celebrex and gabapentin
intraoperative IV acetaminophen, dexamethasone, zofran
postoperative scheduled IV acetaminophen, PO celebrex and gabapentin, and as needed PO narcotics
patient will be discharged on scheduled ibuprofen and acetaminophen for 3 days followed by &quot;as needed&quot; use as well as &quot;as needed&quot; narcotics</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Celebrex</intervention_name>
    <arm_group_label>Multimodal</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Gabapentin</intervention_name>
    <arm_group_label>Multimodal</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>IV acetaminophen</intervention_name>
    <arm_group_label>Multimodal</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>oral acetaminophen</intervention_name>
    <arm_group_label>Standard</arm_group_label>
    <arm_group_label>Multimodal</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>oral ibuprofen</intervention_name>
    <arm_group_label>Standard</arm_group_label>
    <arm_group_label>Multimodal</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>percocet</intervention_name>
    <arm_group_label>Standard</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>vicodin</intervention_name>
    <arm_group_label>Standard</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxycodone</intervention_name>
    <arm_group_label>Multimodal</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dilaudid</intervention_name>
    <arm_group_label>Standard</arm_group_label>
    <arm_group_label>Multimodal</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone</intervention_name>
    <arm_group_label>Multimodal</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>zofran</intervention_name>
    <arm_group_label>Multimodal</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  women &gt;/= 18 years old

          -  undergoing pelvic organ prolapse or incontinence surgery with the Urogynecology
             department

        Exclusion Criteria:

          -  males

          -  &lt;18 years old

          -  women unwilling or unable to consent

          -  same-day-discharge surgery

          -  history of chronic pain for which they use medications

          -  current or active history of narcotic abuse

          -  sleep apnea

          -  liver or kidney dysfunction

          -  sulfa allergy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Krista Reagan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hartford Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hartford Hosptial</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 7, 2014</study_first_submitted>
  <study_first_submitted_qc>April 8, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 10, 2014</study_first_posted>
  <last_update_submitted>August 15, 2016</last_update_submitted>
  <last_update_submitted_qc>August 15, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 17, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>narcotic use</keyword>
  <keyword>pain</keyword>
  <keyword>constipation</keyword>
  <keyword>nausea</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constipation</mesh_term>
    <mesh_term>Nausea</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Ibuprofen</mesh_term>
    <mesh_term>Celecoxib</mesh_term>
    <mesh_term>Ondansetron</mesh_term>
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Oxycodone</mesh_term>
    <mesh_term>Gabapentin</mesh_term>
    <mesh_term>Hydromorphone</mesh_term>
    <mesh_term>BB 1101</mesh_term>
    <mesh_term>Narcotics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

